US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aspire Biopharma Holdings Inc.

8.91

-0.0700-0.78%

Post-market: 8.910.00000.00%16:10 EDT

Volume:59.66K

Turnover:536.00K

Market Cap:12.50M

PE:-1.04

High:9.25

Open:8.74

Low:8.74

Close:8.98

52wk High:704.52

52wk Low:3.31

Shares:1.40M

Float Shares:1.11M

Volume Ratio:3.10

T/O Rate:5.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-8.5310

EPS(LYR):-491.2689

ROE:-1032.14%

ROA:60.58%

PB:1.06

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Aspire Biopharma Holdings Inc - Does Not Anticipate New Equity Raise for Purchase - SEC Filing

THOMSON REUTERS

Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY

Benzinga Earnings

Aspire Biopharma unit Buzz Bomb Caffeine signs national retail distribution deal with TruLife

Buzz Bomb Caffeine Company names John Choe Western Sales Director

Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Showcases BUZZ BOMB at HFA Show 2026

Aspire Biopharma launches BUZZ BOMB Covenience Store Pack

Aspire Biopharma Partners With Microsize on Sublingual Alprazolam Powder Development

Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Posts Record Social Media Growth and Sales Surge

Aspire Biopharma Regains Nasdaq Listing Compliance

Aspire Biopharma Holdings Inc. Makes Investor Presentation Available

Aspire Subsidiary Buzz Bomb Caffeine Names ChicExecs PR Agency of Record

BRIEF-Aspire Biopharma Says Resale Of Up To 159.1 Mln Shares Of Common Stock Underlying Series A Convertible Preferred Stock

Aspire Biopharma Holdings Inc: Resale of up to 159,090,906 Shares of Common Stock Underlying Series a Convertible Preferred Stock

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigermoments.com/stock/ASBP/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASBP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","market":"US","secType":"STK","nameCN":"Aspire Biopharma Holdings Inc.","latestPrice":8.91,"timestamp":1788292800000,"preClose":8.98,"halted":0,"volume":59663,"hourTrading":{"tag":"盘后","latestPrice":8.91,"preClose":8.91,"latestTime":"16:10 EDT","volume":95,"amount":846.45,"timestamp":1788293404759,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.007795100222717181,"floatShares":1113605,"shares":1402600,"eps":-8.531,"marketStatus":"Post-Mkt","change":-0.07,"latestTime":"09-01 17:31:30 EDT","open":8.735,"high":9.25,"low":8.735,"amount":535996,"amplitude":0.05735,"askPrice":9.57,"askSize":7352,"bidPrice":8.7,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-8.531,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788307200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":8.98,"preHourTrading":{"tag":"盘前","latestPrice":8.5,"preClose":8.98,"latestTime":"09:29 EDT","volume":753,"amount":6438.133433999999,"timestamp":1788269395981,"change":-0.48,"changeRate":-0.053452,"amplitude":0.038864},"postHourTrading":{"tag":"盘后","latestPrice":8.91,"preClose":8.91,"latestTime":"16:10 EDT","volume":95,"amount":846.45,"timestamp":1788293404759,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.103794},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASBP\",,,,,undefined,":{"symbol":"ASBP","floatShares":1113605,"roa":"60.58%","roe":"-1032.14%","lyrEps":-491.26893,"volumeRatio":3.103794,"shares":1402600,"dividePrice":0,"high":9.25,"amplitude":0.05735,"preClose":8.98,"low":8.735,"week52Low":3.309,"pbRate":"1.06","psRate":"127.97","week52High":704.52,"institutionHeld":0,"latestPrice":8.91,"committee":-0.973162,"eps":-8.531,"divideRate":0,"volume":59663,"delay":0,"ttmEps":-8.531,"open":8.735,"prevYearClose":158.28,"prevWeekClose":8.51,"prevMonthClose":8.98,"prevQuarterClose":5.34,"fiveDayClose":8.27,"twentyDayClose":7.04,"sixtyDayClose":5.34},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASBP\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-11","symbol":"ASBP","defaultRemindTime":1778506200000,"type":"split","dateTimestamp":1778472000000,"forFactor":30,"toFactor":1,"ratio":30},{"market":"US","date":"2026-01-16","symbol":"ASBP","defaultRemindTime":1768573800000,"type":"split","dateTimestamp":1768539600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASBP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASBP\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASBP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASBP","date":"2026-08-31","current":-1.053804,"percent":0.272,"low":-107.647863,"twenty":-1.229759,"median":-0.770189,"eighty":-0.236788,"high":-0.03181,"avg":-6.394349,"sd":15.185906,"marketCap":11935760},"quantilePoints":[{"date":"2025-03-07","current":-61.718107,"twenty":-79.515888,"median":-61.718107,"eighty":-58.474317,"marketCap":40003023},{"date":"2025-03-14","current":-41.62384,"twenty":-63.871064,"median":-57.344015,"eighty":-54.828644,"marketCap":26978783},{"date":"2025-03-21","current":-49.388839,"twenty":-61.718107,"median":-55.259235,"eighty":-45.464716,"marketCap":32011722},{"date":"2025-03-28","current":-47.36506,"twenty":-59.766092,"median":-48.376949,"eighty":-45.613987,"marketCap":30699995},{"date":"2025-04-04","current":-38.75323,"twenty":-56.183571,"median":-46.367595,"eighty":-43.647619,"marketCap":25118177},{"date":"2025-04-11","current":-38.035578,"twenty":-55.34679,"median":-45.929755,"eighty":-40.946376,"marketCap":24653026},{"date":"2025-04-17","current":-39.57853,"twenty":-55.287942,"median":-45.474044,"eighty":-39.546954,"marketCap":25653101},{"date":"2025-04-25","current":-36.428037,"twenty":-53.967461,"median":-44.487272,"eighty":-38.006872,"marketCap":23611087},{"date":"2025-05-02","current":-25.763721,"twenty":-50.875815,"median":-42.879731,"eighty":-36.06634,"marketCap":16698936},{"date":"2025-05-09","current":-24.070062,"twenty":-48.174572,"median":-41.62384,"eighty":-32.456117,"marketCap":15601179},{"date":"2025-05-16","current":-8.64997,"twenty":-47.360753,"median":-40.170558,"eighty":-27.896584,"marketCap":11330354},{"date":"2025-05-23","current":-0.643502,"twenty":-46.76371,"median":-38.75323,"eighty":-25.110657,"marketCap":10952545},{"date":"2025-05-30","current":-1.730761,"twenty":-46.192459,"median":-37.963813,"eighty":-23.557658,"marketCap":29457944},{"date":"2025-06-06","current":-0.976857,"twenty":-45.929755,"median":-36.514155,"eighty":-4.677726,"marketCap":16626329},{"date":"2025-06-13","current":-1.091781,"twenty":-45.929755,"median":-34.956848,"eighty":-1.13913,"marketCap":18582368},{"date":"2025-06-20","current":-0.913361,"twenty":-45.88526,"median":-32.509654,"eighty":-1.103849,"marketCap":15545618},{"date":"2025-06-27","current":-0.879171,"twenty":-45.613987,"median":-30.966702,"eighty":-1.056614,"marketCap":14963696},{"date":"2025-07-03","current":-0.838948,"twenty":-45.240807,"median":-27.672677,"eighty":-0.926003,"marketCap":14279083},{"date":"2025-07-11","current":-0.994957,"twenty":-44.49445,"median":-25.763721,"eighty":-0.89957,"marketCap":16934405},{"date":"2025-07-18","current":-1.022827,"twenty":-44.487272,"median":-24.235121,"eighty":-0.913361,"marketCap":17408745},{"date":"2025-07-25","current":-1.492005,"twenty":-43.705031,"median":-23.47441,"eighty":-0.913361,"marketCap":25394273},{"date":"2025-08-01","current":-1.094942,"twenty":-43.417971,"median":-12.855253,"eighty":-0.926003,"marketCap":18636159},{"date":"2025-08-08","current":-0.957894,"twenty":-42.341491,"median":-1.730761,"eighty":-0.926003,"marketCap":16303583},{"date":"2025-08-15","current":-1.119076,"twenty":-41.810429,"median":-1.408829,"eighty":-0.936633,"marketCap":19046927},{"date":"2025-08-22","current":-1.407348,"twenty":-41.62384,"median":-1.381965,"eighty":-0.948126,"marketCap":26605351},{"date":"2025-08-29","current":-1.458172,"twenty":-41.494663,"median":-1.401585,"eighty":-0.950712,"marketCap":27566154},{"date":"2025-09-05","current":-1.427258,"twenty":-40.909001,"median":-1.428961,"eighty":-0.956458,"marketCap":26981748},{"date":"2025-09-12","current":-1.182832,"twenty":-39.815341,"median":-1.395821,"eighty":-0.96387,"marketCap":22360975},{"date":"2025-09-19","current":-1.153491,"twenty":-39.515377,"median":-1.375367,"eighty":-0.974558,"marketCap":21806284},{"date":"2025-09-26","current":-0.990278,"twenty":-38.902502,"median":-1.341067,"eighty":-0.987594,"marketCap":18720816},{"date":"2025-10-03","current":-1.100309,"twenty":-38.179108,"median":-1.232741,"eighty":-0.956458,"marketCap":20800907},{"date":"2025-10-10","current":-0.881819,"twenty":-37.978166,"median":-1.192915,"eighty":-0.950195,"marketCap":16670441},{"date":"2025-10-17","current":-0.836759,"twenty":-37.504515,"median":-1.176427,"eighty":-0.934507,"marketCap":15818594},{"date":"2025-10-24","current":-0.880247,"twenty":-36.758157,"median":-1.164494,"eighty":-0.913361,"marketCap":16640725},{"date":"2025-10-31","current":-0.986087,"twenty":-36.462484,"median":-1.14993,"eighty":-0.912711,"marketCap":18641575},{"date":"2025-11-07","current":-0.694243,"twenty":-35.704643,"median":-1.134878,"eighty":-0.909799,"marketCap":13124382},{"date":"2025-11-14","current":-0.275601,"twenty":-35.070237,"median":-1.124309,"eighty":-0.898954,"marketCap":5210132},{"date":"2025-11-21","current":-0.235902,"twenty":-33.9751,"median":-1.119076,"eighty":-0.881505,"marketCap":4838687},{"date":"2025-11-28","current":-0.553115,"twenty":-32.997658,"median":-1.106147,"eighty":-0.854611,"marketCap":11360337},{"date":"2025-12-05","current":-0.481425,"twenty":-32.429349,"median":-1.100309,"eighty":-0.832214,"marketCap":9887900},{"date":"2025-12-12","current":-0.546836,"twenty":-31.853289,"median":-1.093218,"eighty":-0.820326,"marketCap":11231365},{"date":"2025-12-19","current":-0.524858,"twenty":-30.859054,"median":-1.081231,"eighty":-0.778555,"marketCap":10779960},{"date":"2025-12-26","current":-0.507589,"twenty":-29.773963,"median":-1.072669,"eighty":-0.702707,"marketCap":10425286},{"date":"2026-01-02","current":-0.690217,"twenty":-28.344399,"median":-1.050409,"eighty":-0.690255,"marketCap":14176239},{"date":"2026-01-09","current":-0.540556,"twenty":-26.497162,"median":-1.035468,"eighty":-0.662273,"marketCap":11102392},{"date":"2026-01-16","current":-0.271586,"twenty":-26.171348,"median":-1.031821,"eighty":-0.631908,"marketCap":5578064},{"date":"2026-01-23","current":-0.236788,"twenty":-25.763721,"median":-1.0257,"eighty":-0.565151,"marketCap":4863341},{"date":"2026-01-30","current":-0.191,"twenty":-25.584308,"median":-1.01392,"eighty":-0.553115,"marketCap":3922916},{"date":"2026-02-06","current":-0.172685,"twenty":-24.400181,"median":-1.00377,"eighty":-0.544219,"marketCap":3546746},{"date":"2026-02-13","current":-0.171377,"twenty":-24.070062,"median":-0.994957,"eighty":-0.524858,"marketCap":3519876},{"date":"2026-02-20","current":-0.359587,"twenty":-23.760036,"median":-0.986087,"eighty":-0.515752,"marketCap":7385488},{"date":"2026-02-27","current":-0.354694,"twenty":-23.516034,"median":-0.961629,"eighty":-0.507589,"marketCap":7285005},{"date":"2026-03-06","current":-0.320448,"twenty":-23.365326,"median":-0.950712,"eighty":-0.493983,"marketCap":6581626},{"date":"2026-03-13","current":-0.275194,"twenty":-18.316039,"median":-0.944432,"eighty":-0.472111,"marketCap":5652159},{"date":"2026-03-20","current":-0.160836,"twenty":-10.332083,"median":-0.936633,"eighty":-0.400965,"marketCap":3303373},{"date":"2026-03-27","current":-0.222601,"twenty":-3.353645,"median":-0.92313,"eighty":-0.358608,"marketCap":4571969},{"date":"2026-04-02","current":-0.20728,"twenty":-1.850282,"median":-0.913361,"eighty":-0.349802,"marketCap":5074383},{"date":"2026-04-10","current":-0.246272,"twenty":-1.619708,"median":-0.910113,"eighty":-0.3317,"marketCap":6028948},{"date":"2026-04-17","current":-0.061568,"twenty":-1.539071,"median":-0.901599,"eighty":-0.30661,"marketCap":1507237},{"date":"2026-04-24","current":-0.044124,"twenty":-1.518322,"median":-0.89649,"eighty":-0.291771,"marketCap":1080186},{"date":"2026-05-01","current":-0.045417,"twenty":-1.507267,"median":-0.886242,"eighty":-0.278584,"marketCap":1111838},{"date":"2026-05-08","current":-0.03181,"twenty":-1.498068,"median":-0.879171,"eighty":-0.273751,"marketCap":778739},{"date":"2026-05-15","current":-0.040156,"twenty":-1.471705,"median":-0.838948,"eighty":-0.253079,"marketCap":983048},{"date":"2026-05-22","current":-0.079589,"twenty":-1.447326,"median":-0.833201,"eighty":-0.24422,"marketCap":936157},{"date":"2026-05-29","current":-0.078735,"twenty":-1.438334,"median":-0.830472,"eighty":-0.238761,"marketCap":926109},{"date":"2026-06-05","current":-0.086138,"twenty":-1.433681,"median":-0.820052,"eighty":-0.233015,"marketCap":1013193},{"date":"2026-06-12","current":-0.085426,"twenty":-1.429302,"median":-0.809929,"eighty":-0.222924,"marketCap":1004820},{"date":"2026-06-18","current":-0.090552,"twenty":-1.423276,"median":-0.772866,"eighty":-0.215898,"marketCap":1065109},{"date":"2026-06-26","current":-0.710801,"twenty":-1.405043,"median":-0.722364,"eighty":-0.218511,"marketCap":8360735},{"date":"2026-07-02","current":-0.645282,"twenty":-1.395821,"median":-0.717257,"eighty":-0.222397,"marketCap":7590071},{"date":"2026-07-10","current":-0.668406,"twenty":-1.391891,"median":-0.710801,"eighty":-0.222601,"marketCap":7862070},{"date":"2026-07-17","current":-0.691531,"twenty":-1.381965,"median":-0.692082,"eighty":-0.223409,"marketCap":8134069},{"date":"2026-07-24","current":-0.793939,"twenty":-1.368769,"median":-0.694243,"eighty":-0.230247,"marketCap":9338637},{"date":"2026-07-31","current":-0.739982,"twenty":-1.363165,"median":-0.710801,"eighty":-0.231574,"marketCap":8703972},{"date":"2026-08-07","current":-0.777422,"twenty":-1.345206,"median":-0.71717,"eighty":-0.23229,"marketCap":9144352},{"date":"2026-08-14","current":-0.782927,"twenty":-1.340648,"median":-0.720161,"eighty":-0.233644,"marketCap":9209113},{"date":"2026-08-21","current":-0.992645,"twenty":-1.256688,"median":-0.732274,"eighty":-0.235513,"marketCap":10967995},{"date":"2026-08-28","current":-1.048497,"twenty":-1.230952,"median":-0.767511,"eighty":-0.236611,"marketCap":11585120},{"date":"2026-08-31","current":-1.080232,"twenty":-1.229759,"median":-0.770189,"eighty":-0.236788,"marketCap":11935760}],"updateTime":1788279336920},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASBP\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2627283793","title":"Aspire Biopharma Holdings Inc - Does Not Anticipate New Equity Raise for Purchase - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2627283793","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627283793?lang=en_us&edition=fundamental","pubTime":"2026-04-15 18:31","pubTimestamp":1776249078,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nFWN40Y0BG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626058920","title":"Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2626058920","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626058920?lang=en_us&edition=fundamental","pubTime":"2026-04-09 06:00","pubTimestamp":1775685657,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(1.84) per share. This is a 67.27 percent decrease over losses of $(1.10) per share from the same period last year.  The company reported $4.261 thousand","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/04/51720943/aspire-biopharma-hldgs-q4-eps-1-84-down-from-1-10-yoy-sales-4-261k-up-from-0-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Aspire Biopharma Hldgs Q4 EPS $(1.84) Down From $(1.10) YoY, Sales $4.261K Up From $0 YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620247254","title":"Aspire Biopharma unit Buzz Bomb Caffeine signs national retail distribution deal with TruLife","url":"https://stock-news.laohu8.com/highlight/detail?id=2620247254","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620247254?lang=en_us&edition=fundamental","pubTime":"2026-03-19 20:02","pubTimestamp":1773921732,"startTime":"0","endTime":"0","summary":"Aspire Biopharma’s wholly owned unit Buzz Bomb Caffeine Company reached an agreement with TruLife Distribution for TruLife to manage sales, distribution and merchandising of BUZZ BOMB to retailers nationwide.The arrangement targets expansion into natural, organic, specialty and mass-merchandiser retail channels.BUZZ BOMB is sold as single-serving stick packs containing 50 mg of caffeine in a dry powder intended for under-the-tongue use.Kraig Higginson and Brian Gould commented on the agreement.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260319:nNDL5SyJFg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620422858","title":"Buzz Bomb Caffeine Company names John Choe Western Sales Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2620422858","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620422858?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:31","pubTimestamp":1773750666,"startTime":"0","endTime":"0","summary":"Buzz Bomb Caffeine, a wholly owned subsidiary of Aspire Biopharma, appointed John Choe as Western Sales Director. Choe previously served as a district manager at Yerbaé from 2016 to 2025. Yerbaé reported a 70% increase in overall sales during Choe’s tenure.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDLbsN8br:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618314211","title":"Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Showcases BUZZ BOMB at HFA Show 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618314211","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618314211?lang=en_us&edition=fundamental","pubTime":"2026-03-12 20:00","pubTimestamp":1773316848,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc.’s wholly owned subsidiary, Buzz Bomb Caffeine Company, will showcase its flagship BUZZ BOMB caffeine product in the New Product Zone at The Health & Fitness Show 2026 in San Diego on March 16-18. BUZZ BOMB is a 50mg caffeine dry powder in single-serving stick packs designed for under-the-tongue use.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nNDL72Hsf1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618953981","title":"Aspire Biopharma launches BUZZ BOMB Covenience Store Pack","url":"https://stock-news.laohu8.com/highlight/detail?id=2618953981","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618953981?lang=en_us&edition=fundamental","pubTime":"2026-03-10 20:51","pubTimestamp":1773147097,"startTime":"0","endTime":"0","summary":"Aspire Biopharma (ASBP) Holdings is expanding its retail footprint with the launch of the BUZZ BOMB Convenience Store Pack. The lineup includes the...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-launches-buzz-bomb-covenience-store-pack-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aspire-biopharma-launches-buzz-bomb-covenience-store-pack-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616715340","title":"Aspire Biopharma Partners With Microsize on Sublingual Alprazolam Powder Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2616715340","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616715340?lang=en_us&edition=fundamental","pubTime":"2026-03-03 21:01","pubTimestamp":1772542870,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. has partnered with Microsize to accelerate development of a patent-pending, rapid-delivery sublingual powder formulation of alprazolam aimed at faster, more predictable anxiety relief than traditional tablets. The collaboration will leverage Microsize’s particle engineering and micronization capabilities, with Aspire targeting a Phase 1 clinical trial in mid-2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nNDL5c4gdD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614877030","title":"Aspire Biopharma Subsidiary Buzz Bomb Caffeine Company Posts Record Social Media Growth and Sales Surge","url":"https://stock-news.laohu8.com/highlight/detail?id=2614877030","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614877030?lang=en_us&edition=fundamental","pubTime":"2026-02-25 21:30","pubTimestamp":1772026233,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc.’s wholly owned subsidiary, Buzz Bomb Caffeine Company, reported record social media growth and a surge in online revenue following its sponsorship of ultra-marathoner Ashley Paulson at the 2026 Jackpot Ultra Running Festival. Buzz Bomb said its content topped 400,000 views in 48 hours after Paulson set a women’s world record in the USATF 100-Mile Road Championship, and highlighted its 50mg caffeine stick-pack products offered in four flavors.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nNDLdKlbd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612640262","title":"Aspire Biopharma Regains Nasdaq Listing Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=2612640262","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612640262?lang=en_us&edition=fundamental","pubTime":"2026-02-20 21:00","pubTimestamp":1771592447,"startTime":"0","endTime":"0","summary":"Aspire Biopharma said Nasdaq has confirmed the company regained compliance with continued listing rules, including the $2.5 million minimum stockholders’ equity requirement and the $1.00 minimum bid price rule, allowing its shares to remain listed. Nasdaq also placed Aspire under a one-year “Panel Monitor” through Feb. 18, 2027, meaning any renewed equity deficiency would require a hearing before a Nasdaq panel rather than submission of a standard compliance plan.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260220:nNDL4nG6PJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612400084","title":"Aspire Biopharma Holdings Inc. Makes Investor Presentation Available","url":"https://stock-news.laohu8.com/highlight/detail?id=2612400084","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612400084?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:33","pubTimestamp":1771508032,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc. published an investor presentation titled “Aspire Biopharma Investor Presentation February 2026,” available at I Accept.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aspire Biopharma Holdings Inc. published the original content used to generate this news brief on February 19, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL2yTnMs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612407701","title":"Aspire Subsidiary Buzz Bomb Caffeine Names ChicExecs PR Agency of Record","url":"https://stock-news.laohu8.com/highlight/detail?id=2612407701","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612407701?lang=en_us&edition=fundamental","pubTime":"2026-02-19 21:00","pubTimestamp":1771506038,"startTime":"0","endTime":"0","summary":"Aspire Biopharma Holdings Inc.’s wholly owned subsidiary, Buzz Bomb Caffeine Company, has named ChicExecs as its public relations agency of record. ChicExecs will lead BUZZ BOMB communications strategy, including media relations, events, strategic partnerships, and PR-led campaign planning, as the brand pursues expansion, product innovation, and a refreshed market presence.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL1Ctr4W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612493620","title":"BRIEF-Aspire Biopharma Says Resale Of Up To 159.1 Mln Shares Of Common Stock Underlying Series A Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2612493620","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612493620?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:43","pubTimestamp":1771364593,"startTime":"0","endTime":"0","summary":"BRIEF-Aspire Biopharma Says Resale Of Up To 159.1 Mln Shares Of Common Stock Underlying Series A Convertible Preferred StockFeb 17  - Aspire Biopharma Holdings Inc ASBP.O:ASPIRE BIOPHARMA HOLDINGS INC: RESALE OF UP TO 159,090,906 SHARES OF COMMON STOCK UNDERLYING SERIES A CONVERTIBLE PREFERRED STOCKSource text: [ID:n0001493152-26-007123]Further company coverage: ASBP.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASBP","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612983214","title":"Aspire Biopharma Holdings Inc: Resale of up to 159,090,906 Shares of Common Stock Underlying Series a Convertible Preferred Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2612983214","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612983214?lang=en_us&edition=fundamental","pubTime":"2026-02-18 05:19","pubTimestamp":1771363158,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nFWN3ZD0TP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ASBP"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":53,"code":"91000000","status":"200"}]}}